Rothschild & CO Asset Management Us Inc. Boston Scientific Corp Transaction History
Rothschild & CO Asset Management Us Inc.
- $6.56 Billion
- Q4 2022
A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 2,225,689 shares of BSX stock, worth $236 Million. This represents 1.57% of its overall portfolio holdings.
Number of Shares
2,225,689
Previous 1,224,301
81.79%
Holding current value
$236 Million
Previous $47.4 Million
117.23%
% of portfolio
1.57%
Previous 0.81%
Shares
11 transactions
Others Institutions Holding BSX
# of Institutions
1,655Shares Held
1.22BCall Options Held
8.72MPut Options Held
9.6M-
Vanguard Group Inc Valley Forge, PA133MShares$14.1 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY126MShares$13.4 Billion0.22% of portfolio
-
State Street Corp Boston, MA64MShares$6.79 Billion0.23% of portfolio
-
Primecap Management CO Pasadena, CA36.9MShares$3.92 Billion2.61% of portfolio
-
Wellington Management Group LLP Boston, MA36.2MShares$3.84 Billion0.61% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $152B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...